
<?xml version='1.0' encoding='UTF-8'?>
<article>
<front>
<journal-meta>
<journal-id journal-id-type='publisher'>IJRAP</journal-id>
<journal-title>International Journal of Research in Ayurveda and Pharmacy</journal-title>
<issn pub-type='ppub'>2277-4343</issn>
 <publisher>
<publisher-name>Moksha Publishing House </publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type='other'>10.7897/2277-4343.175164</article-id>
<title-group>
<article-title>CLINICAL EFFICACY OF HIMASAGARA TAILA SHIROPICHU AND ORAL YASHTIMADHU CHURNA IN THE MANAGEMENT OF PERIMENOPAUSAL SYNDROME: A CASE REPORT
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type='author'>
<name>Shweta C Dindur</name>
</contrib>
<contrib contrib-type='author'>
<name> Veenashree A *</name>
</contrib>
</contrib-group>
<pub-date>
<month>11</month>
<year>-0001</year>
</pub-date>
<fpage>9</fpage>
<lpage>12</lpage>
<abstract><title>Abstract</title>
Background: Perimenopausal syndrome is a transition phase before menopause and may present with irregular menstruation, hot flushes, mood swings, sleep disturbances and impaired concentration. In Ayurveda, this period may be understood in relation to age-associated vata predominance, dhatu kshaya (tissue depletion) and rasakshaya (depletion of rasa dhatu). Objective: to assess the clinical response to himasahara taila shiropichu (continuous application of medicated oil over the scalp) and oral Yahstimadhu churna (liquorice powder) in a patient with perimenopausal syndrome. Case presentation: A 42-year-old woman presented with irregular menstrual cycles, hot flushes, mood swings, disturbed sleep and poor concentration for six months. The baseline Greene Climacteric Scale (GCS) was 35. Intervention: Yashtimadhu churna 2g twice daily with milk before food was administered for 30 days, along with Himasagara taila shiropichu for 30 minutes daily for seven consecutive days. Outcome: The total GCS Score decreased from 35 before treatment to 22 after treatment and was 23 at one-month follow-up. Improvement was observed in somatic, psychological and vasomotor symptoms, sleep quality and menstrual well-being, without reports of adverse effects. Conclusion: The intervention showed clinical improvement in this single case. Controlled studies with larger samples are required to determine its efficacy and safety.
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>Shiropichu</kwd>
<kwd> Rasayana</kwd>
<kwd> Medhyarasayana</kwd>
<kwd> Himasagara taila</kwd>
<kwd> Perimenopausal syndrome</kwd>
<kwd> Rajonivrutti</kwd>
<kwd> Striroga.</kwd>
</kwd-group>
<counts><ref-count count='0'/><page-count count='5'/></counts>
</article-meta></front><back><ref-list><title>References</title></ref-list></back></article>
